Terms: = Endocrine gland cancer AND TP63, EEC3, 8626, ENSG00000073282, p73H, p63, Q9H3D4, TP73L, p51, OFC8, KET, RHS, B p51B , B p51A , SHFM4, LMS, p73L AND Clinical Outcome
6 results:
1. Positive
Huang S; Qi M; Tian T; Dai H; Tang Y; Huang R
Front Endocrinol (Lausanne); 2022; 13():959089. PubMed ID: 36407316
[TBL] [Abstract] [Full Text] [Related]
2. TLR5/7-mediated PI3K activation triggers epithelial-mesenchymal transition of ovarian cancer cells through WAVE3-dependent mesothelin or OCT4/SOX2 expression.
Park GB; Kim D
Oncol Rep; 2017 Nov; 38(5):3167-3176. PubMed ID: 28901470
[TBL] [Abstract] [Full Text] [Related]
3. Microarray-based oncogenic pathway profiling in advanced serous papillary ovarian carcinoma.
Trinh XB; Tjalma WA; Dirix LY; Vermeulen PB; Peeters DJ; Bachvarov D; Plante M; Berns EM; Helleman J; Van Laere SJ; van Dam PA
PLoS One; 2011; 6(7):e22469. PubMed ID: 21799864
[TBL] [Abstract] [Full Text] [Related]
4. DeltaNp63 expression is associated with poor survival in ovarian cancer.
Marchini S; Marabese M; Marrazzo E; Mariani P; Cattaneo D; Fossati R; Compagnoni A; Fruscio R; Lissoni AA; Broggini M
Ann Oncol; 2008 Mar; 19(3):501-7. PubMed ID: 17998283
[TBL] [Abstract] [Full Text] [Related]
5. Basaloid carcinoma of the pancreas.
Marucci G; Betts CM; Liguori L; Eusebi V
Virchows Arch; 2005 Mar; 446(3):322-4. PubMed ID: 15726404
[TBL] [Abstract] [Full Text] [Related]
6. Ceruminous adenomas: a clinicopathologic study of 41 cases with a review of the literature.
Thompson LD; Nelson BL; Barnes EL
Am J Surg Pathol; 2004 Mar; 28(3):308-18. PubMed ID: 15104293
[TBL] [Abstract] [Full Text] [Related]
